Similar articles

• Tangier disease as a test of the reverse cholesterol transport hypothesis.

  Tall AR, Wang N. Tall AR, et al. J Clin Invest. 2000 Nov;106(10):1205-7. doi: 10.1172/JCI11538. J Clin Invest. 2000. PMID: 11086021 Free PMC article. Review. No abstract available.
• The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

  Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C, Porsch-Ozcürümez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. Bodzioch M, et al. Nat Genet. 1999 Aug;22(4):347-51. doi: 10.1038/11914. Nat Genet. 1999. PMID: 10431237
• Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency.

  Hayden MR, Clee SM, Brooks-Wilson A, Genest J Jr, Attie A, Kastelein JJ. Hayden MR, et al. Curr Opin Lipidol. 2000 Apr;11(2):117-22. doi: 10.1097/00041433-200004000-00003. Curr Opin Lipidol. 2000. PMID: 10787172 Review.
• ABC1: connecting yellow tonsils, neuropathy, and very low HDL.

  Hobbs HH, Rader DJ. Hobbs HH, et al. J Clin Invest. 1999 Oct;104(8):1015-7. doi: 10.1172/JCI8509. J Clin Invest. 1999. PMID: 10525038 Free PMC article. No abstract available.
• Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1.

  Oram JF. Oram JF. Trends Mol Med. 2002 Apr;8(4):168-73. doi: 10.1016/s1471-4914(02)02289-x. Trends Mol Med. 2002. PMID: 11927274 Review.